This matters for our region too: dementia prevalence in Arab countries ranges between 1.1% and 2.3% among those 50+, climbing to 13.518.5% among those 80 and older (PubMed Central) and as Gulf healthcare systems push toward home-care models and reduced hospital burden, this kind of label change is exactly the type of precedent local regulators (SFDA, MoPH, NHRA) will be watching: how do you extend access to complex biologics without compromising safety oversight
Ishy PL, Fagerlund B, Broberg BV, et al
Current evidence from large-scale clinical trials and regulatory surveillance does not establish a causal link between GLP-1 receptor agonists and increased risk of venous thromboembolism (deep vein thrombosis or pulmonary embolism)
Semaglutide helps control your appetite and reduce your food intake, while lipotropic injections boost your metabolism and help your body burn fat more efficiently
However, true allergic reactions are extremely rare